Just as ChatGPT predicts the next word, Epic's AI trained on medical records predicts patient trajectories

Slower uptake of generative AI in public health provides a unique opportunity to embed community accountability before more of these models are fully...

Third Rock Ventures delivered the best returns among 22 prominent biotech venture capital firms analyzed by STAT.

The Undiagnosed Diseases Network, a research group that tries to identify rare diseases sickening children, is caught up in the government's fight wit...

A top Democratic senator is launching an investigation into privately owned methadone clinics’ business practices and treatment of patients.

Medical research is becoming more aligned with global disease burden as a side effect of chronic diseases becoming more prevalent worldwide.

Images of President Trump’s bruised hand have renewed attention to his health in general and his cardiovascular health in particular.

Akeso, a Chinese biotech with a drug positioned to rival Merck’s Keytruda, reported that its lung cancer therapy can improve patient survival.

The industry group MassBio has released its annual temperature check on the biotech industry in Massachusetts, and the results are grim.

AbbVie agreed to pay up to $1.2 billion to buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression